Can a cancer drug restore gout treatment? small study tests rituximab

NCT ID NCT06186219

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested whether a drug called rituximab could help people with severe, hard-to-treat gout respond again to a medication (pegloticase) that had stopped working for them. Only 2 people took part, and the main goal was to see if the approach was safe and possible. The study was completed, but results are not yet widely reported.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TOPHACEOUS GOUT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UCLA

    Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.